Antihypertensive neutral lipid
A method is described for treating a warm-blooded animal comprising administering to the animal a neutral glycerolipid with a 12 to 20 carbon alkyl group at the sn-1 position, a short carbon chain acyl group at the sn-2 position and a hydroxyl group at the sn-3 position in an amount sufficient to lower the arterial blood pressure of the animal. A method is also described for treating a warm-blooded animal comprising administering a composition consisting essentially of a 1-alkyl-2-acetyl (or propionyl)-sn glycerol in combination with a 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine, wherein the 1-alkyl groups contain 12 to 20 carbon atoms, dissolved in an inert pharmaceutically acceptable solvent in amounts sufficient to lower the arterial blood pressure of the animal.
- Assignee:
- Dept. of Energy, Washington, DC
- Patent Number(s):
- US 4595681
- OSTI ID:
- 5578512
- Resource Relation:
- Patent File Date: Filed date 26 Oct 1984
- Country of Publication:
- United States
- Language:
- English
Similar Records
Antihypertensive neutral lipid
Alkyl phospholipid antihypertensive agent. [US Patent Application]
Related Subjects
ANTIHYPERTENSIVE AGENTS
HYPERTENSION
THERAPY
LIPIDS
THERAPEUTIC USES
BLOOD PRESSURE
CARBON
DISSOLUTION
QUANTITY RATIO
CARDIOVASCULAR AGENTS
CARDIOVASCULAR DISEASES
DISEASES
DRUGS
ELEMENTS
NONMETALS
ORGANIC COMPOUNDS
SYMPTOMS
USES
VASCULAR DISEASES
550600* - Medicine